Recent Headlines
Within Pharmaceuticals
MedShorts Announces Promotion of Blake Powers to President
MedShorts, an Orlando-based e-commerce software solution specializing in connecting pharmacies with pharmaceutical manufacturers to source short-dated and short-supply medications, announced the promotion of Blake Powers to President of the company. After serving as the company’s Chief Operating Officer over the past five years, Blake has advanced to leading the company at a time when hospitals face significant financial pressure to reduce costs within their facilities. - May 06, 2021 - MedShorts LLC
EligibilityAdvocates – New Patient Eligibility Service Powered by HealthWare Systems
HealthWare Systems has partnered with a new company, EligibilityAdvocates, which offers patient eligibility and out-of-state Medicaid billing services. The new organization is powered by HealthWare Systems’ revenue cycle technology solutions. EligibilityAdvocates’ on-site patient... - May 06, 2021 - HealthWare Systems
NAMI Atlantic/Cape May Kicks Off National Mental Health Awareness Month with a New Website That Emphasizes Hope
The non-profit Atlantic/Cape May (ACM) affiliate of NAMI amplifies the important message, “You Are Not Alone,” for people in Atlantic and Cape May counties with a mental health condition in its new website at https://namiacm.org/. ACM’s new website makes it easy to access clear concise information on mental health topics including Information about free peer-led programs that meet the needs of those living with a mental health condition, and support programs for their families and friends. - May 05, 2021 - NAMI Atlantic/Cape May
North American Pet Health Insurance Market Continued Double-Digit Growth in 2020
The North American Pet Health Insurance Association (NAPHIA) today reported that North America’s pet insurance sector exceeded $2.174 billion USD in 2020, recording its sixth consecutive year of double-digit growth. The industry continued its growth trajectory despite the... - May 04, 2021 - NAPHIA - North American Pet Health Insurance Association
NIDCAP Federation International Releases Episodes 4 & 5 in Podcast Series, NICU Care with NIDCAP
The NIDCAP Federation International proudly presents two new podcast episodes in their series, NICU Care with NIDCAP. Episodes 4 and 5 are now available. Produced by The NIDCAP Federation International, alongside Jeff Bradbury of TeacherCast Educational Network and funded by Jennifer Degl of... - May 03, 2021 - NIDCAP Federation International
Paras Biopharmaceuticals Finland Oy is Named as One of the Top 30 Admired Companies to Watch 2021
Paras Biopharmaceuticals Finland Oy, a fast-growing, biopharmaceutical technology development company, based in Oulu, Finland, announced today that it is named as one of the top 30 admired companies to watch during 2021, by CIO Bulletin, USA. - April 28, 2021 - Paras Biopharmaceuticals Finland Oy
Foster Institute Receives IRB Approval to Proceed with Development of a National Registry on the Safety and Utilization of Hemp Cannabinoids
Foster Institute LLC, a Kentucky based think tank and research institute, announced today it has received Institutional Review Board (“IRB”) protocol approval for the development of the first mobile technology led national registry on the safety and utilization of Hemp... - April 28, 2021 - Foster Institute
Linshom Receives SBIR Phase II Contract Award from the United States Air Force for Its Dual Purpose Respiratory Device
Linshom announced today receipt of a phase II SBIR contract award with the United States Air Force (USAF) to fund ongoing development and deployment of the Linshom Predictive Continuous Respiratory Monitoring (LPCRM) System. The $748K contract follows successful completion of a SBIR phase 1 award... - April 27, 2021 - Linshom
USDA BioPreferred Program Certifies Locus Performance Ingredients Biosurfactants as 100% Biobased
Formulators can use Ferma™ S or Amphi™ M renewable sophorolipids as sustainable, high-performance alternatives to chemical surfactants in CPG formulations. - April 24, 2021 - Locus Performance Ingredients
Courage Therapeutics Awarded STTR Grant to Design Novel Anorexia Drugs
Courage Therapeutics has been awarded an STTR grant by the National Insittute of Mental Health to design novel anorexia drugs. The grant is a follow-up to research by the Cone lab at the University of Michigan that recently published in Science Translational Research that MC3R is a potential target for therapeutic development in anorexia and obesity. The effort allows for an expeditious translation of basic science into eating disorders which have remained an area of significant unmet need. - April 23, 2021 - Courage Therapeutics
Careington Announces Completion of New Corporate Campus in Frisco
Careington International Corporation celebrated the recent completion of its new corporate campus located in Frisco, Texas. This facility is an addition to Careington’s international headquarters, which includes two buildings also located in Frisco. This new campus was developed to address... - April 23, 2021 - Careington
Temperatures Are Rising – It's Time to Check Your Cooling Towers
As Texas and other parts of the country start to heat up, cooling towers will be in full use. Hyperion Biotechnology offers Legionella testing to monitor for bacteria growth to help reduce the risk of spread from cooling towers. - April 21, 2021 - Hyperion Biotechnology, Inc.
The NIDCAP Federation International Releases a Podcast Series Called NICU Care with NIDCAP, Following World NIDCAP Day 2021
The NIDCAP Federation International releases a podcast series called NICU Care With NIDCAP following the celebrations of World NIDCAP Day 2021. In each episode, best practices are discussed to support the health and development of hospitalized newborns, infants and their families, and those that care for them, in intensive care nursery settings and beyond. - April 17, 2021 - NIDCAP Federation International
Mitolytix Novel Biomolecule Converts Malignant Phenotype to Benign Status
A new biomolecule developed my Mitolytix Research, referred to as a "Catalyst," significantly induce necrosis of malignant tumors without histological changes in adjacent nontumorous tissue. The objective is tumor “normalization,” in contrast to “expeditious tumor destruction.” While some similarities between the tumor response of chemo-radiotherapy and the catalyst are observed, several differences are noted. - April 17, 2021 - Mitolytix
Adexilis Adria Opened
Adexilis Adria is the latest company established within the Adexilis network. Adexilis Adria covers the markets Croatia, Slovenia, Serbia, Bosnia Herzegovina, and Macedonia. The initial focus and products will be in Gastroenterology and Women's Health. The aim is to search for cutting edge... - April 17, 2021 - Adexilis Schweiz AG
Court Square Group and 5thPort Announce Life Science Industry Partnership
Court Square Group and 5thPort’s Partnership helps life science companies streamline clinical trials and procedures, increase regulatory compliance, and shorten time to market. - April 15, 2021 - Court Square Group
New Chief Information Security Officer Named at Lifelines Neuro
Rafael Garrido brings cloud security expertise for expansion of Rendr Platform EEG software. - April 15, 2021 - Lifelines Neuro
Families of World War II Veterans Takes Part in Frisco Veteran’s 100th Birthday Celebration
Families of World War II Veterans is excited to announce it took part in a special birthday celebration in Frisco in honor of World War II veteran Burnie Sutter’s 100th birthday on Saturday, April 10. To help commemorate the birthday of this war hero, Families of World War II Veterans... - April 11, 2021 - Careington
Ambit, Inc. Announces the Release of AmbitVPN’s Post-Quantum Native Windows Application
Ambit, Inc., a US based post-quantum cybersecurity company, announces the release of AmbitVPN’s Post-Quantum Windows desktop - www.ambitvpn.com. This new native VPN Windows application is 4x faster than the initial beta while achieving near-line speed on internal tests. This positions the company’s Post-Quantum VPN as a market leader in speed and security for their users on Android and iOS mobile apps, as well as Mac desktop. Linux desktop users will have AmbitVPN soon too. - April 08, 2021 - Ambit Inc.
Derek Builders Invites You to "Experience the Derek Difference" - New Brand Identity, Same Service, Standards, and Values
Derek Engineering, Inc., a full-service general contractor specializing in commercial and industrial construction, announced today the launch of a new brand identity and trade name. The Arizona based general contractor, spearheaded by Southwest Region President, Jeff Bateman, will now operate as... - April 07, 2021 - Derek Builders
uMore, the AI-Powered Mental Wellbeing Tracker, Becomes the First UAE-Based Start-Up Accepted to TheVentureCity
uMore is the first UAE-based start-up to be accepted to join TheVentureCity, an international, operator-led venture acceleration model built by Laura González-Estéfani, Facebook's ex-Head of Growth, Mobile and Partnerships for Latin America. - April 03, 2021 - uMore
Y-Biologics & Pierre Fabre: Confirmation of Research Partnership in Oncology
Y-Biologics and Pierre Fabre confirm their research collaboration for the development of new immunotherapies in oncology. - March 31, 2021 - Pierre Fabre
GeneThera, Inc. Wastewater Testing: a Way to Better Control the COVID-19 Pandemic
The global COVID-19 pandemic has demonstrated that neither current systems nor related technologies are capable of preventing or even successfully controlling the spread of zoonotic infectious agents. One of the prominent features of these infectious organisms is their ability to infect both people... - March 30, 2021 - GeneThera Inc.
Newest Weapon in the Fight Against COVID 19 - Bi-Polar Ionization System Tests Positive for Killing Coronavirus
The scientific study was conducted by Hylabs and followed the stringent guidelines developed by the Israeli Ministry of Health. The tests concluded that the Sterionizer D6 and D5 units were capable of inactivating hCoV-OC43; an acceptable model for SARS-CoV-2 which causes COVID-19. Medcare Medical Devices Canada is a Canadian importer and authorized distributor of the Sterionizer family of ionizer systems. They have the products registered under their MDEL license with Health Canada. - March 25, 2021 - MedCare Medical Devices Canada
Courage Therapeutics Raises $1M for Treatment of Anorexia Nervosa and Other Related Eating Disorders
Courage Therapeutics raised $1M towards development of treatments for eating disorders including Anorexia Nervosa, ARFID, BED and genetic obesity. The company is led by Dan Housman a parent of children with eating disorders. The round was led by Michigan Biomedical Ventures. Funding will be used to test Courage’s proprietary compounds in animal models of eating disorders. The technology is based on the research on MC3R at the University of Michigan from co-founder Dr. Roger Cone’s lab. - March 24, 2021 - Courage Therapeutics
CyboSoft Releases pH Control System Design Guide to Help Customers Comply with EPA Rules and Achieve Quick ROI
CyboSoft's pH Control System Design Guide can help industrial plants meet wastewater discharge codes, save chemical reagents, and improve plant safety and productivity. - March 22, 2021 - CyboSoft
Portland Trainer Attempts to Break World Record for Heaviest Weight Lifted by Kettlebell Swing
To demonstrate the incredible power of consistency and the body's ability to heal, Portland-based personal trainer and life enhancement enthusiast Steven Herrera will be continuously swinging a kettlebell through a full range of motion for an hour straight. Herrera is taking on this challenge in an effort to break the current Guinness World Record and also hopes to raise awareness for diabetes. - March 18, 2021 - Stick-To-It Fitness
Mitolytix: Innovative Biomolecule to Treat Cancer Shows Promise in Early Studies
Mitolytix Research Ltd.(TM) is a private company dedicated to developing innovative cancer treatments. - March 17, 2021 - Mitolytix
Clay Walker to Give Keynote Speech at Online Event to Benefit National Multiple Sclerosis Society
The 17th Annual On the Move Luncheon, presented by Biogen, and one of the most inspiring events in the Washington spring social season, will be held virtually on Thursday, May 20, 2021 at 12pm. This year’s program features prominent country star Clay Walker and his wife Jessica Walker sharing their personal journey with multiple sclerosis. - March 17, 2021 - National Multiple Sclerosis Society
AbboMax Introduces a Panel of Monoclonal and Polyclonal Anti-Connexin Antibodies
AbboMax introduces a panel of monoclonal and polyclonal anti-connexin antibodies. There are 21 different types of connexins which are known to exist in humans and 20 types in mice. Their abnormal expression and function are associated with human hereditary diseases. AbboMax has been developing & manufacturing high performance immunoassay reagents for many years in California. - March 15, 2021 - AbboMax, Inc.
Zifo RnD Solutions Bags the Fastest Growing Company Award at Deloitte Technology Fast 50 2020
Zifo RnD Solutions has been featuring in this list since 2012 and is the only company in India to have won this award 9 years in a row. - March 15, 2021 - Zifo
Eurofins Viracor BioPharma Launches PanCancerIQ Comprehensive Genomic Profiling Service to Advance Precision Oncology Clinical Drug Development
Eurofins Viracor BioPharma Services, a global leader in specialty bioanalytical testing services, announces the launch of their new PanCancerIQ genomic profiling test; a next-generation sequencing (NGS) service that enables comprehensive genomic profiling of tumor samples. In addition to expanding... - March 11, 2021 - Eurofins Viracor BioPharma
MEDraysintell Publishes Its New Proton Therapy World Report & Directory, Edition 2021
Proton therapy market headwinds: demand down, supply up, but increasing awareness. - March 06, 2021 - MEDraysintell
Jason Amada's 5 Tips to Become a Successful Medical Rep
Jason Amada is a New York-based medical sales representative who started his career in the field of Finance. In 2019, he made the switch to medicine and considers it to be one of the best decisions of his life. His long-lost love for medicine was realized with his career transition. He has been... - March 04, 2021 - Jason Amada: Medical Sales
Intrinsic Imaging Undergoes Third FDA Inspection with No 483 Observations
Intrinsic Imaging recently underwent an extensive inspection by the U.S. Food and Drug Administration (FDA). The FDA determined Intrinsic Imaging was in complete compliance with all federal regulations and the company received zero 483 observations. This was Intrinsic Imaging's third FDA inspection and its third inspection with no findings. - March 01, 2021 - Intrinsic Imaging, LLC
emeds becomes Pakistan’s First International Standard Pharmacy as It Moves Towards Expansion
Pakistani health-tech startup, emeds.pk becomes Pakistan’s first digital retail pharmacy to achieve ISO 9001 certification. Launched less than a year ago, after partnering with foreign investors, emeds has taken strides to establish itself as a reliable digital health partner. As access to... - March 01, 2021 - emeds
AbboMax is Pleased to Introduce the Collection of Monoclonal and Polyclonal Anti-STAT Antibodies
STAT proteins (Signal transducers and activators of transcription) are cytoplasmic transcription factors that play an essential role in transmitting signals from the cellular membrane to the nucleus. Misregulation of STAT pathway frequently leads to tumorogenesis. AbboMax introduces a panel of monoclonal and polyclonal anti-STAT antibodies. - February 27, 2021 - AbboMax, Inc.
Wharton Alumnae Strategic Partnership Lays Foundation of American Ecosystem for PPE
MedEquip Depot (Dallas, TX) is pleased to announce a strategic partnership with SA Ventures (New York, NY) through their affiliate SA Work Wear. The partnership is designed to build a reliable and sustainable supply chain ecosystem for PPE made in the Americas. Through SA Ventures' strategic relationships with material producers and FDA registered factories in the Americas, this partnership reinforces and secures the ability to meet local demand without influence from Asian markets. - February 26, 2021 - MedEquip Depot
Stargardt Disease - MD Stem Cells New Treatment Improves Vision
Stem Cell Ophthalmology Treatment Study (SCOTS) show positive results in 84% of eyes. - February 18, 2021 - MD Stem Cells
Paras Biopharmaceuticals Finland Oy Affordable Healthcare Efforts Viewed in Over 90 Countries: Biosimilar Technologies Get Attention
Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is a Finland-based microbial biologics company which focuses on the development of technologies for biosimilars and biologics in an efficient manner. The overall objective of Paras Biopharma is to enable economical production and future availability of affordable medicines for unmet medical needs. - February 17, 2021 - Paras Biopharmaceuticals Finland Oy
Phase One Development of Rapid COVID-19 Point of Care Test Complete
Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. - February 11, 2021 - Pepex Biomedical, Inc.
Collection Services Provide Peace of Mind in Fight Against Legionella Bacteria
Hyperion Biotechnology expands Legionella water collection services in several California cities and other U.S. locations. Facility owners can schedule services to support their water safety plans. - February 11, 2021 - Hyperion Biotechnology, Inc.
Saeidan Publishes New Report: A Look Back on Medicare Annual Enrollment 2021
Saeidan, a solutions company seeking to transform the Medicare experience, has published a new analytics-based report on "A Look Back at Medicare Annual Enrollment 2021:Key Findings and Implications." This third comprehensive report from Saeidan, based on primary and secondary research,... - February 10, 2021 - Saeidan
Cayman Adds Nordic BioSite as Trusted Distributor
Cayman Chemical’s complete assay kit, protein, antibody, and biochemical portfolio is now more accessible to Denmark, Finland, Iceland, Norway, Sweden, and the Baltic countries as well as Russia through a distribution agreement with Nordic BioSite. Headquartered in Täby, Sweden, Nordic... - February 10, 2021 - Cayman Chemical Company
Careington® Announces Launch of National Teledentistry Program
Careington is introducing an innovative teledentistry program through affiliate company DialCare. - February 05, 2021 - Careington
Careington, a Proud Sponsor of Annual Dr. Martin Luther King, Jr. Essay and Oration Scholarship Competition
Careington is proud to have once again served as a "Dream" level sponsor for the 11th annual Dr. Martin Luther King, Jr. Essay and Oration Scholarship competition. This annual event is hosted by Linking Cultures of Frisco, a Frisco-based non-profit organization with a mission to connect... - January 29, 2021 - Careington
Linshom Announces European Patent Coverage for the Linshom Continuous Respiratory Monitor
Linshom announced today receipt of patents in five European countries including Germany, France, Spain, Italy and Great Britain. This adds to and expands the current Linshom patent portfolio held in the United States, Canada, Japan, Mexico and China. The lack of a simple, portable and inexpensive... - January 28, 2021 - Linshom
Kevin Sarney Joins Charles River CFO to Lead Life Sciences Practice
Charles River CFO, Inc. (CRCFO), a provider of part-time and interim CFO and accounting services, today announced Kevin Sarney has joined the leadership team as the Life Sciences Practice Leader and CFO. With over 20 years of experience in public and private life sciences companies, Kevin will lead... - January 21, 2021 - Charles River CFO
New Industry UKARA Association Launched to Ensure UK Authorised Representative and Responsible Person Standards Expected by the UK Government
The UK Competent Authority for medical devices, the MHRA, requires manufacturers not domiciled in the UK must appoint a formal UK Responsible Person (UKRP) or UK Authorised Representative (UKAR) to be able to continue placing medical devices on the UK market. Following several months’... - January 21, 2021 - UKARA
AltuCell Therapeutics Announces Proof-of-Concept in Lead Programs in Type 1 Diabetes in Human Subjects; Phase 1 Pilot in Humans Has IND Approval & Trial to Begin Shortly
AltuCell Therapeutics, Inc., AltuCell announced today the achievement of approval of IND in Italy after pre-clinical proof-of-concept based on data from its two lead programs for type 1 diabetes testing of cadaver stem cell-derived islets in both human and non-human subjects. Their capsules have been implanted in people with diabetes for 5 year, demonstrating long-term safety, with no toxicity or tissue necrosis, and no rejection in any of the patients treated. - January 15, 2021 - AltuCell Therapeutics